Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP).

Helmut Salzer; et al.

doi:10.1055/a-2182-1609

Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP).

Helmut Salzer
, et al.

Klinische Abteilung für Infektiologie und Tropenmedizin

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Originalsprache	Englisch
Seiten (von - bis)	35-46
Seitenumfang	12
Fachzeitschrift	Pneumologie
Volume	78
Ausgabenummer	1
DOIs	https://doi.org/10.1055/a-2182-1609
Publikationsstatus	Veröffentlicht - Okt. 2023

UN SDGs

Dieser Output leistet einen Beitrag zu folgendem(n) Ziel(en) für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Wissenschaftszweige

303031 Tropenmedizin
302030 Innere Medizin

Zugriff auf Dokument

10.1055/a-2182-1609

Andere Dateien und Links

Verknüpfung zur Publikation in Scopus

Dieses zitieren

Salzer, H., & et al. (2023). Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP). Pneumologie, 78(1), 35-46. https://doi.org/10.1055/a-2182-1609

Salzer, Helmut ; et al. / Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP). in: Pneumologie. 2023 ; Jahrgang/Volume 78, Nr. 1. S. 35-46.

@article{5b527f7ffb0944149b558a6b6bf319ba,

title = "Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP).",

author = "Helmut Salzer and \{et al.\}",

year = "2023",

month = oct,

doi = "10.1055/a-2182-1609",

language = "English",

volume = "78",

pages = "35--46",

journal = "Pneumologie",

issn = "1438-8790",

number = "1",

}

Salzer, H & et al. 2023, 'Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP).', Pneumologie, Jg. 78, Nr. 1, S. 35-46. https://doi.org/10.1055/a-2182-1609

Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP). / Salzer, Helmut; et al.
in: Pneumologie, Volume 78, Nr. 1, 10.2023, S. 35-46.

Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

TY - JOUR

T1 - Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP).

AU - Salzer, Helmut

AU - et al., null

PY - 2023/10

Y1 - 2023/10

UR - https://www.scopus.com/pages/publications/85182727041

U2 - 10.1055/a-2182-1609

DO - 10.1055/a-2182-1609

M3 - Article

SN - 1438-8790

VL - 78

SP - 35

EP - 46

JO - Pneumologie

JF - Pneumologie

IS - 1

ER -

Salzer H, et al. Treatment of MDR, pre-XDR, XDR and rifampicin resistant tuberculosis or in case of intolerance to at least rifampicin in Austria, Germany and Switzerland - Amendment dated 19.09.2023 to the Sk2-Guideline: Tuberculosis in adulthood of the German Central Committee against Tuberculosis (DZK) on behalf of the German Respiratory Society (DGP). Pneumologie. 2023 Okt.;78(1):35-46. doi: 10.1055/a-2182-1609